Metipranolol adverse reactions: Difference between revisions
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Metipranolol}} {{CMG}} == <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD...." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Adverse Reactions== | ||
In clinical trials, the use of metipranolol ophthalmic solution has been associated with transient local discomfort. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | Other ocular adverse reactions, such as abnormal vision, blepharitis, blurred vision, browache, conjunctivitis, edema, eyelid dermatitis, photophobia, tearing, and uveitis have been reported in small numbers of patients. | ||
Other systemic adverse reactions, such as allergic reaction, angina, anxiety, arthritis, asthenia, atrial fibrillation, bradycardia, bronchitis, coughing, depression, dizziness, dyspnea, epistaxis, headache, hypertension, myalgia, myocardial infarct, nausea, nervousness, palpitation, rash, rhinitis, and somnolence have also been reported in small numbers of patients.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 05:23, 10 February 2014
| Metipranolol |
|---|
| METIPRANOLOL® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Metipranolol |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse Reactions
In clinical trials, the use of metipranolol ophthalmic solution has been associated with transient local discomfort.
Other ocular adverse reactions, such as abnormal vision, blepharitis, blurred vision, browache, conjunctivitis, edema, eyelid dermatitis, photophobia, tearing, and uveitis have been reported in small numbers of patients.
Other systemic adverse reactions, such as allergic reaction, angina, anxiety, arthritis, asthenia, atrial fibrillation, bradycardia, bronchitis, coughing, depression, dizziness, dyspnea, epistaxis, headache, hypertension, myalgia, myocardial infarct, nausea, nervousness, palpitation, rash, rhinitis, and somnolence have also been reported in small numbers of patients.[1]
References
Adapted from the FDA Package Insert.